INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🟢 Indaptus Therapeutics is trading 6% up in pre-market after narrower second-quarter loss
Indaptus Therapeutics is trading at $1.09 (+5.83%) now after releasing second-quarter 2026 results on August 13, 2026, which showed net loss narrowed to...
Indaptus Therapeutics second quarter 2026 net loss narrows to $1.8M amid clinical trial halt
Indaptus reported a significant reduction in operating expenses for the second quarter of 2026 as the company effectively halted its active clinical...
🔴 Indaptus Therapeutics is trading 10.08% down today with no confirmed company-specific announcement
Indaptus Therapeutics is trading 10.08% down at $1.07, with no confirmed company-specific announcement identified for August 12, 2026. - Search results show...
🔴 Indaptus Therapeutics is trading 5.46% down today — no confirmed company-specific catalyst
Indaptus Therapeutics is trading 5.46% down at $1.12 based on the provided live price context; searches found no confirmed company-specific announcement on...
🟢 Indaptus Therapeutics is trading 5.89% up today with no confirmed company-specific catalyst
Indaptus Therapeutics is trading $1.26, up +5.89%, with no confirmed company-specific announcement explaining the August 11, 2026 gain. - Investors may be...
Indaptus Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Analysts expect Indaptus Therapeutics to report a consensus EPS loss of -$0.36 for Q2 2026 on zero revenue, with the stock currently trading at $1.56 against...
🟢 Indaptus Therapeutics is trading 5.81% up in pre-market with no clear catalyst identified
Indaptus Therapeutics is trading 5.81% up at $1.25 after no clear company-specific catalyst was identified for August 10, 2026. - Its virtual annual meeting...
🔴 Indaptus Therapeutics is trading 10.24% down today — no clear company-specific catalyst
Indaptus Therapeutics is trading 10.24% down now at $1.19 after searches found no clear company-specific announcement explaining the August 6, 2026 decline. -...
🔴 Indaptus Therapeutics is trading 9.78% down today — no clear company-specific catalyst
Indaptus Therapeutics is trading 9.78% down now at $1.20 after no clear company-specific catalyst emerged in the August 6, 2026 news search. - Recent coverage...
🟢 Indaptus Therapeutics is trading 14.29% up today on speculative trading with no clear catalyst
Indaptus Therapeutics is trading at $1.52 (+14.29%) in pre-market sessions despite a lack of identifiable company-specific catalysts in current news flow. *...
🟢 Indaptus Therapeutics is trading 5.3% up today on technical buying and risk-on sentiment
Indaptus Therapeutics is trading 5.3% up at $1.38 as the stock stages a technical rebound following a sharp multi-day selloff. • The recovery follows a period...
🔴 Indaptus Therapeutics is trading 7.6% down today reversing an earlier technical rebound
Indaptus Therapeutics is trading at $1.21 (7.6% down) in after-hours trading, reversing part of a sharp intraday rebound. • The stock climbed approximately...
🟢 Indaptus Therapeutics is trading 10.1% up today on a technical rebound after a sharp multi-day selloff
Indaptus Therapeutics is trading 10.1% up at $1.42 in what appears to be a technical rebound after a sharp multi-day selloff. • There are no fresh...
🟢 Indaptus Therapeutics is trading 5% up today on a technical rebound after recent declines
Indaptus Therapeutics is trading 5% higher at $1.36 in a technical rebound following several days of sharp declines and profit-taking. • The move comes...
🔴 Indaptus Therapeutics is trading 10.4% down today after continued post-rally profit-taking
Indaptus Therapeutics is trading at $1.29 (-10.42%) as the stock faces a second day of sharp selling driven by post-rally profit-taking following a steep...
🔴 Indaptus Therapeutics is trading 5.6% down today on continued post-rally profit-taking
Indaptus Therapeutics is trading 5.6% down at $1.36 as traders continue to lock in gains following the stock's recent sharp rebound. • The decline follows a...
🔴 Indaptus Therapeutics is trading 13.5% down today on profit-taking after a multi-day rebound
Indaptus Therapeutics is trading 13.5% down at $1.57 as investors engage in profit-taking and short-term selling following a sharp multi-day rally. • The...
🔴 Indaptus Therapeutics is trading 5.8% down today on profit-taking after recent rebound
Indaptus Therapeutics is trading 5.8% down at $1.72 on profit-taking following a sharp multi-day rebound. • The stock's decline follows a period of...
🟢 Indaptus Therapeutics is trading 6.6% up today on broader market rebound
Indaptus Therapeutics is trading at $1.94 (+6.6%) in pre-market sessions, recovering from yesterday’s risk-off driven after-hours decline. • The upward move...
🔴 Indaptus Therapeutics is trading 7.1% down today amid thin after-hours liquidity and a broader risk-off backdrop
Indaptus Therapeutics is trading at $1.69 (-7.14%) in after-hours trading after closing the regular session at $1.82, with the move appearing to be driven by...